Blog

DSCSA Compliance 2026: How to Meet FDA Traceability Requirements with Bonbloc’s Onelign MarginShield

The pharmaceutical industry is entering a new era of supply chain transparency.

The Drug Supply Chain Security Act (DSCSA) requires pharmaceutical trading partners to support electronic traceability, product verification, and secure data exchange across the supply chain.

While the industry has been preparing for years, the compliance timeline continues to evolve. For many pharmacies and dispensers, November 27, 2026 represents a critical milestone for meeting DSCSA requirements.

The challenge is not simply compliance.

The challenge is creating a pharmaceutical supply chain that is traceable, secure, and prepared for audits, investigations, recalls, and verification requests.

This is where Onelign MarginShield- DSCSA helps.

What is DSCSA?

The Drug Supply Chain Security Act (DSCSA) is a U.S. federal law designed to improve pharmaceutical supply chain security through serialization, traceability, and electronic data exchange.

The objective is to improve visibility across the pharmaceutical supply chain and help organizations identify and respond to potentially illegitimate products.

DSCSA Requirements Focus On
  • Product Serialization
  • Package-level Verification
  • Electronic Transaction Data Exchange
  • EPCIS Interoperability
  • Trading Partner Validation
  • Product Tracing
  • Compliance Reporting

The objective is to improve visibility across the pharmaceutical supply chain and help organizations identify and respond to potentially illegitimate products.

DSCSA Compliance Deadline: Why 2026 Matters

The enhanced DSCSA 2023 requirements established electronic, interoperable product tracing across the pharmaceutical supply chain.

While the original DSCSA November 2023 milestone marked the industry's transition to enhanced traceability requirements, FDA implementation timelines and exemptions have extended compliance obligations for certain organizations.

Key Compliance Date November 27, 2026 For many pharmacies and dispensers
Organizations that have not modernized their DSCSA processes should use this period to strengthen:
Serialization workflows
EPCIS data exchange
Product verification
Traceability systems
Trading partner connectivity
Compliance reporting

Waiting until the last minute can create operational and compliance risks.

The Challenge with Traditional DSCSA Compliance

Many pharmaceutical organizations still rely on disconnected systems, spreadsheets, manual verification processes, and fragmented data sources.

As transaction volumes increase, these approaches create challenges such as:

Limited Supply Chain Visibility

Organizations struggle to track product movement across multiple trading partners.

Manual Verification Processes

Verifying serialized products manually increases effort and slows operations.

EPCIS Data Management Complexity

Data quality issues, duplicate records, and incomplete transaction information can create compliance challenges.

Recall and Investigation Delays

When products must be investigated or recalled, locating accurate information quickly becomes difficult.

Audit Preparation Burdens

Compliance evidence often exists across multiple systems and requires significant manual effort to compile.

These challenges make DSCSA compliance more difficult than it needs to be.

Introducing Onelign MarginShield - DSCSA

Onelign MarginShield- DSCSA is Bonbloc's pharmaceutical traceability and compliance platform designed to simplify DSCSA compliance while improving visibility across the supply chain.

The platform helps pharmaceutical organizations manage critical compliance activities through a connected digital workflow.

Instead of handling serialization, verification, traceability, and reporting separately, organizations can manage them through a unified platform.

Key Features of Onelign MarginShield- DSCSA

Electronic Data Exchange

Support secure exchange of DSCSA transaction data and EPCIS information between trading partners.

Serialized Product Verification

Verify products using GTIN, serial number, lot number, and expiration data.

End-to-End Traceability

Track product movement across the pharmaceutical supply chain with greater visibility and transparency.

Blockchain-Powered Security

Leverage blockchain technology to support trusted and tamper-resistant transaction records.

GS1 DataHub Integration

Validate product information and improve data accuracy through GS1 integration.

Exception and Quarantine Management

Automatically identify, manage, and route exceptions through predefined workflows.

Trading Partner Onboarding

Accelerate onboarding and connectivity across manufacturers, distributors, wholesalers, and dispensers.

Compliance Reporting

Generate compliance records, transaction history, verification logs, and audit-ready reports from a centralized system.

Why Choose Onelign MarginShield- DSCSA?

Organizations evaluating solutions such as TraceLink DSCSA, Inmar DSCSA, or other pharmaceutical traceability platforms are looking for the same outcome:

Reliable compliance with minimal operational disruption.

MarginShield- DSCSA helps organizations:

Improve DSCSA compliance readiness
Reduce manual compliance effort
Enhance pharmaceutical traceability
Improve supply chain visibility
Accelerate product verification
Strengthen audit preparedness
Support recall and investigation processes
Improve trading partner collaboration

The result is a more connected and efficient compliance operation.

Preparing for DSCSA Compliance in 2026

DSCSA compliance is no longer just a regulatory initiative.

It is becoming a core requirement for pharmaceutical supply chain operations.

Organizations that invest early in serialization, verification, EPCIS interoperability, and traceability capabilities will be better positioned to meet evolving FDA expectations and industry requirements.

With the 2026 compliance milestone approaching, now is the time to evaluate whether your current systems can support the next phase of pharmaceutical traceability.

Onelign MarginShield- DSCSA helps pharmaceutical organizations simplify compliance, improve visibility, and build a more secure pharmaceutical supply chain.

Frequently Asked Questions (FAQs)

DSCSA stands for the Drug Supply Chain Security Act, a U.S. law that establishes requirements for pharmaceutical product tracing, verification, and supply chain security.
The DSCSA 2023 requirements focus on enhanced electronic interoperability, product verification, serialized tracing, and secure data exchange between trading partners.
For many pharmacies and dispensers, November 27, 2026 is a significant compliance milestone under current FDA implementation timelines.
DSCSA serialization requires pharmaceutical products to carry unique identifiers that support package-level traceability and verification.
EPCIS is a standard used to exchange supply chain event information between pharmaceutical trading partners.
Onelign MarginShield- DSCSA helps organizations manage serialization, verification, traceability, EPCIS exchange, compliance reporting, and trading partner connectivity through a single platform.

Categories